Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study

Visit-to-visit variability in systolic blood pressure (SBP) is a risk factor for cardiovascular events. However, whether it provides additional predictive information beyond traditional risk factors, including mean SBP, in the long term is unclear. The ADVANCE trial (Action in Diabetes and Vascular...

Bibliografske podrobnosti
Main Authors:	Ohkuma, T, Woodward, M, Jun, M, Muntner, P, Hata, J, Colagiuri, S, Harrap, S, Mancia, G, Poulter, N, Williams, B, Rothwell, P, Chalmers, J
Format:	Journal article
Jezik:	English
Izdano:	American Heart Association 2017

Podobne knjige/članki

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
od: Ohkuma, T, et al.
Izdano: (2019)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
od: Hata, J, et al.
Izdano: (2013)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
od: Hata, J, et al.
Izdano: (2013)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
od: Rahman, F, et al.
Izdano: (2019)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
od: Mohammedi, K, et al.
Izdano: (2017)

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study
od: Blomster, J, et al.
Izdano: (2017)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
od: Rådholm, K, et al.
Izdano: (2018)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
od: Zoungas, S, et al.
Izdano: (2012)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON
od: Jun, M, et al.
Izdano: (2017)

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
od: Jun, M, et al.
Izdano: (2017)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
od: Ohkuma, T, et al.
Izdano: (2018)

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.
od: Rothwell, P, et al.
Izdano: (2010)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
od: Hata, J, et al.
Izdano: (2012)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
od: Hua, X, et al.
Izdano: (2020)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
od: Mohammedi, K, et al.
Izdano: (2016)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
od: van Steen, S, et al.
Izdano: (2018)

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
od: Kengne, A, et al.
Izdano: (2009)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
od: Patel, A, et al.
Izdano: (2007)

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes
od: Mohammedi, K, et al.
Izdano: (2016)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
od: Patel, A, et al.
Izdano: (2008)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
od: Woodward, M, et al.
Izdano: (2016)

Severe Hypoglycemia and Risks of Vascular Events and Death
od: Zoungas, S, et al.
Izdano: (2010)

ADAMTS13 is a Risk Factor for MI, Stroke and Vascular Death in the Oxford Vascular Study
od: Eglinton, J, et al.
Izdano: (2008)

Halving premature death.
od: Peto, R, et al.
Izdano: (2014)

Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
od: Atkins, A, et al.
Izdano: (2017)

Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.
od: Glasziou, P, et al.
Izdano: (2010)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
od: Woodward, M, et al.
Izdano: (2016)

Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.
od: Clarke, P, et al.
Izdano: (2010)

Regression dilution of systolic and diastolic blood pressure in patients with established cerebrovascular disease.
od: Howard, S, et al.
Izdano: (2003)

Systemic predisposition to carotid Plaque surface irregularity and coronary vascular death
od: Rothwell, P, et al.
Izdano: (2000)

Blood pressure, cholesterol and premature death
od: Lewington, S, et al.
Izdano: (1999)

Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial
od: Ohkuma, T, et al.
Izdano: (2017)

Strategies to meet the need for long-term data
od: Chalmers, J, et al.
Izdano: (2016)

Risk of coronary and other nonstroke vascular death in relation to the presence and extent of atherosclerotic disease at the carotid bifurcation.
od: Touzé, E, et al.
Izdano: (2006)

Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016
od: Peters, S, et al.
Izdano: (2019)

Tricuspid Annular Plane Systolic Excursion-to-Systolic Pulmonary Artery Pressure Ratio as a Prognostic Factor in Heart Transplant Patients
od: Laurentiu Huma, et al.
Izdano: (2024-06-01)

Changes in left ventricular systolic function after transcatheter patent ductus arteriosus closure in premature infants
od: Aravinth Karunanandaa, et al.
Izdano: (2023-01-01)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
od: Mohammedi, K, et al.
Izdano: (2018)

Lowering blood pressure reduces renal events in type 2 diabetes.
od: de Galan, B, et al.
Izdano: (2009)

Vascular cytoprotection, autoimmune disease, and premature atherosclerosis
od: Justin C Mason
Izdano: (2018-01-01)